Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasman Moshiri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|February 24, 2024
Self-Inflicted Laser-Induced RetinopathyNinel Z Gregori, Louis Cai, Yasman Moshiri
Future Oncology (London, England)|January 29, 2021
How we treat Merkel cell carcinoma: within and beyond current guidelinesSong Y Park, Coley Doolittle-Amieva, Yasman Moshiri, et al.
Quantitative Imaging in Medicine and Surgery|November 1, 2019
Handheld swept-source optical coherence tomography with angiography in awake premature neonatesYasman Moshiri, Alex T Legocki, Kanheng Zhou, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 1, 2022
Vitreous opacities in infants born full-term and preterm by handheld swept-source optical coherence tomographyN Maxwell Scoville, Alex T Legocki, Phanith Touch, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 27, 2021
Dome-shaped macula in premature infants visualized by handheld spectral-domain optical coherence tomographyAlex T Legocki, Yasman Moshiri, Emily M Zepeda, et al.
Translational Vision Science & Technology|May 24, 2023
Multivariate Models to Diagnose Early Referral-Warranted Retinopathy of Prematurity With Handheld Optical Coherence TomographyAlex T Legocki, Aaron Y Lee, Leona Ding, et al.
JAMA Dermatology|February 23, 2022
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From DiagnosisAubriana M McEvoy, Kristina Lachance, Daniel S Hippe, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockadeLisa Tachiki, Yasman Moshiri, Daniel S Hippe, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|February 24, 2024
Self-Inflicted Laser-Induced RetinopathyNinel Z Gregori, Louis Cai, Yasman Moshiri
Future Oncology (London, England)|January 29, 2021
How we treat Merkel cell carcinoma: within and beyond current guidelinesSong Y Park, Coley Doolittle-Amieva, Yasman Moshiri, et al.
Quantitative Imaging in Medicine and Surgery|November 1, 2019
Handheld swept-source optical coherence tomography with angiography in awake premature neonatesYasman Moshiri, Alex T Legocki, Kanheng Zhou, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 1, 2022
Vitreous opacities in infants born full-term and preterm by handheld swept-source optical coherence tomographyN Maxwell Scoville, Alex T Legocki, Phanith Touch, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 27, 2021
Dome-shaped macula in premature infants visualized by handheld spectral-domain optical coherence tomographyAlex T Legocki, Yasman Moshiri, Emily M Zepeda, et al.
Translational Vision Science & Technology|May 24, 2023
Multivariate Models to Diagnose Early Referral-Warranted Retinopathy of Prematurity With Handheld Optical Coherence TomographyAlex T Legocki, Aaron Y Lee, Leona Ding, et al.
JAMA Dermatology|February 23, 2022
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From DiagnosisAubriana M McEvoy, Kristina Lachance, Daniel S Hippe, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockadeLisa Tachiki, Yasman Moshiri, Daniel S Hippe, et al.
Pageof 1